207 related articles for article (PubMed ID: 10344388)
1. Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents.
Moroni G; Faricciotti A; Cappelletti M; Ponticelli C
Nephrol Dial Transplant; 1999 May; 14(5):1303-5. PubMed ID: 10344388
[No Abstract] [Full Text] [Related]
2. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
Ardiles LG; Mezzano SA
Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
[No Abstract] [Full Text] [Related]
3. Retroperitoneal fibrosis associated with membranous nephropathy effectively treated with steroids.
Shirota S; Tsuchiya K; Takada M; Komeda M; Oomae K; Ogawa T; Yumura W; Nitta K; Nihei H
Intern Med; 2002 Jan; 41(1):20-5. PubMed ID: 11838585
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
Wetzels JF; Reichert LJ
Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969
[No Abstract] [Full Text] [Related]
6. Mesenteric arterial thrombosis complicating the nephrotic syndrome.
McGregor DO; Bailey RR
N Z Med J; 1997 Feb; 110(1038):62-3. PubMed ID: 9076292
[No Abstract] [Full Text] [Related]
7. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
8. Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease.
Suki WN; Trimarchi H; Frommer JP
Am J Nephrol; 1999; 19(4):474-9. PubMed ID: 10460937
[TBL] [Abstract][Full Text] [Related]
9. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
Branten AJ; Reichert LJ; Koene RA; Wetzels JF
QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470
[TBL] [Abstract][Full Text] [Related]
10. Retreatment of membranous nephropathy with steroids and chlorambucil after initial unresponsiveness to alternate-day prednisone.
Tietjen DP
Clin Nephrol; 1990 Mar; 33(3):152. PubMed ID: 2323113
[No Abstract] [Full Text] [Related]
11. Effective treatment of idiopathic membranous nephropathy.
Matsumoto Y; Amano I
Nephron; 2000 Dec; 86(4):507-8. PubMed ID: 11124604
[No Abstract] [Full Text] [Related]
12. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
13. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Muñoz Díaz AB; Aguilar P
Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic membranous nephropathy associated with polycystic kidney disease.
Kengne-Wafo S; Massella L; Diomedi-Camassei F; Emma F
Pediatr Nephrol; 2010 May; 25(5):961-3. PubMed ID: 20033222
[TBL] [Abstract][Full Text] [Related]
16. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
Naumovic R; Furuncic D; Jovanovic D; Stosovic M; Basta-Jovanovic G; Lezaic V
Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab.
Dedinská I; Svetlík D; Adamicova K; Machalekova K; Makovicky P; Jezikova A; Laca L; Miklusica J; Galajda P; Mokan M
Iran J Kidney Dis; 2016 Sep; 10(5):332-335. PubMed ID: 27721233
[TBL] [Abstract][Full Text] [Related]
18. [Fatigue, loss of appetite and anuria due to retroperitoneal fibrosis].
de Beus E; Rensma PL
Ned Tijdschr Geneeskd; 2007 Jan; 151(3):161-6. PubMed ID: 17288338
[TBL] [Abstract][Full Text] [Related]
19. [Membranous nephropathy and crescentic glomerulonephritis].
Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
[TBL] [Abstract][Full Text] [Related]
20. Disseminated cutaneous plasmacellular granuloma associated with membranous glomerulonephritis.
Querfeld U; Groth W; Eder EF; Hoppe B; Sollberg S
Nephrol Dial Transplant; 1999 May; 14(5):1268-71. PubMed ID: 10344377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
